Collins MK - Search Results

1

Lentiviral vector followed by protein immunisation breaks tolerance against the self-antigen Her1 and results in lung cancer immunotherapy.

Alpizar YA, Karwacz K, Arce F, Yglesias Rivera A, Fernández LE, Collins MK, Sánchez Ramírez B. Alpizar YA, et al. Among authors: collins mk. J Gene Med. 2012 Mar;14(3):151-7. doi: 10.1002/jgm.2606. J Gene Med. 2012. PMID: 22262303

2

Lentiviral vectors transduce proliferating dendritic cell precursors leading to persistent antigen presentation and immunization.

Arce F, Rowe HM, Chain B, Lopes L, Collins MK. Arce F, et al. Among authors: collins mk. Mol Ther. 2009 Sep;17(9):1643-50. doi: 10.1038/mt.2009.149. Epub 2009 Jul 7. Mol Ther. 2009. PMID: 19584812 Free PMC article.

3

Ten years of progress in vaccination against cancer: the need to counteract cancer evasion by dual targeting in future therapies.

Alpizar YA, Chain B, Collins MK, Greenwood J, Katz D, Stauss HJ, Mitchison NA. Alpizar YA, et al. Among authors: collins mk. Cancer Immunol Immunother. 2011 Aug;60(8):1127-35. doi: 10.1007/s00262-011-0985-7. Epub 2011 Apr 9. Cancer Immunol Immunother. 2011. PMID: 21479639 Free PMC article. Review.

4

HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7.

Breckpot K, Escors D, Arce F, Lopes L, Karwacz K, Van Lint S, Keyaerts M, Collins M. Breckpot K, et al. J Virol. 2010 Jun;84(11):5627-36. doi: 10.1128/JVI.00014-10. Epub 2010 Mar 17. J Virol. 2010. PMID: 20237085 Free PMC article.

5

PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells.

Karwacz K, Bricogne C, MacDonald D, Arce F, Bennett CL, Collins M, Escors D. Karwacz K, et al. EMBO Mol Med. 2011 Oct;3(10):581-92. doi: 10.1002/emmm.201100165. Epub 2011 Aug 10. EMBO Mol Med. 2011. PMID: 21739608 Free PMC article.

6

Targeting lentiviral vectors for cancer immunotherapy.

Arce F, Breckpot K, Collins M, Escors D. Arce F, et al. Curr Cancer Ther Rev. 2011 Nov;7(4):248-260. doi: 10.2174/157339411797642605. Curr Cancer Ther Rev. 2011. PMID: 22983382 Free PMC article.

7

Harnessing alveolar macrophages for sustained mucosal T-cell recall confers long-term protection to mice against lethal influenza challenge without clinical disease.

Macdonald DC, Singh H, Whelan MA, Escors D, Arce F, Bottoms SE, Barclay WS, Maini M, Collins MK, Rosenberg WM. Macdonald DC, et al. Among authors: collins mk. Mucosal Immunol. 2014 Jan;7(1):89-100. doi: 10.1038/mi.2013.27. Epub 2013 May 29. Mucosal Immunol. 2014. PMID: 23715172 Free article.

8

Selective ERK activation differentiates mouse and human tolerogenic dendritic cells, expands antigen-specific regulatory T cells, and suppresses experimental inflammatory arthritis.

Arce F, Breckpot K, Stephenson H, Karwacz K, Ehrenstein MR, Collins M, Escors D. Arce F, et al. Arthritis Rheum. 2011 Jan;63(1):84-95. doi: 10.1002/art.30099. Arthritis Rheum. 2011. PMID: 20967853 Free PMC article.

9

Nonintegrating lentivector vaccines stimulate prolonged T-cell and antibody responses and are effective in tumor therapy.

Karwacz K, Mukherjee S, Apolonia L, Blundell MP, Bouma G, Escors D, Collins MK, Thrasher AJ. Karwacz K, et al. Among authors: collins mk. J Virol. 2009 Apr;83(7):3094-103. doi: 10.1128/JVI.02519-08. Epub 2009 Jan 28. J Virol. 2009. PMID: 19176629 Free PMC article.

10

Generation of multi-functional antigen-specific human T-cells by lentiviral TCR gene transfer.

Perro M, Tsang J, Xue SA, Escors D, Cesco-Gaspere M, Pospori C, Gao L, Hart D, Collins M, Stauss H, Morris EC. Perro M, et al. Gene Ther. 2010 Jun;17(6):721-32. doi: 10.1038/gt.2010.4. Epub 2010 Feb 18. Gene Ther. 2010. PMID: 20164855

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

205 results

Search Page